Lista substanțelor care prezintă motive de îngrijorare deosebită candidate pentru autorizare
Lista substanțelor care prezintă motive de îngrijorare deosebită candidate pentru autorizare
[publicată în conformitate cu articolul 59 alineatul (10) din Regulamentul REACH]
Lista substanțelor care prezintă motive de îngrijorare deosebită candidate pentru autorizare
Note:
- Versiune autentică: Doar lista substanțelor candidate publicată pe acest site este considerată autentică. În urma includerii unei substanțe pe lista substanțelor candidate de pe acest site, întreprinderile pot avea obligații juridice imediate, de exemplu pe cele stipulate la articolele 7, 31 și 33 din Regulamentul REACH.
- Identificatorii numerici: Fiecare rubrică din lista substanțelor candidate vizează atât forma anhidră, cât și formele hidratate ale substanței. Numărul CAS indicat în cadrul rubricii corespunde de obicei formei anhidre, dar în domeniul de aplicare al rubricii respective sunt incluse și formele hidratate ale substanței, identificate prin alte numere CAS.
- Alți identificatori numerici: Rubricile care au înscris semnul „-” în coloanele referitoare la numărul CE și la numărul CAS cuprind, dacă este posibil din punct de vedere practic, un inventar neexhaustiv al numerelor de registru CE și/sau CAS care descriu substanțele sau grupele de substanțe despre care se consideră că intră sub incidența rubricii respective din lista substanțelor candidate. Aceste informații pot fi accesate făcând clic pe butonul „Details” (Detalii) din cadrul rubricii selectate.
Filter the list
The List does not contain any Substances.
Sunt afişate 1 - 200 rezultate din 240.
Decizie | Setul de date din IUCLID | ||||||
---|---|---|---|---|---|---|---|
with ≥ 0.1% of Michler's ketone (EC No. 202-027-5) or Michler's base (EC No. 202-959-2)
|
229-851-8
|
6786-83-0
|
18-Iun-2012
|
Carcinogenic (Article 57a) |
Details | ||
are fibres covered by index number 650-017-00-8 in Annex VI, part 3, table 3.1 of Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, and fulfil the three following conditions: a) oxides of aluminium, silicon and zirconium are the main components present (in the fibres) within variable concentration ranges b) fibres have a length weighted geometric mean diameter less two standard geometric errors of 6 or less micrometres (µm). c) alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content less or equal to 18% by weight
show/hide
|
-
|
-
|
19-Dec-2011
|
Carcinogenic (Article 57a) |
Details | ||
246-677-8
|
25155-23-1
|
16-Dec-2013
|
Toxic for reproduction (Article 57c) |
Details | |||
show/hide
|
-
|
-
|
16-Iul-2019
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
213-934-0
|
1067-53-4
|
17-Ian-2022
|
Toxic for reproduction (Article 57c) |
Details | |||
204-118-5
|
115-96-8
|
13-Ian-2010
|
Toxic for reproduction (Article 57c) |
Details | |||
235-252-2
|
12141-20-7
|
19-Dec-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
222-979-5
|
3687-31-8
|
19-Dec-2011
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
215-290-6
|
1319-46-6
|
19-Dec-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
-
|
427-700-2
|
15606-95-8
|
28-Oct-2008
|
Carcinogenic (Article 57a) |
Details | ||
206-203-2
|
307-55-1
|
19-Dec-2012
|
vPvB (Article 57e) |
Details | |||
201-167-4
|
79-01-6
|
18-Iun-2010
|
Carcinogenic (Article 57a) |
Details | |||
235-380-9
|
12202-17-4
|
19-Dec-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
201-075-4
|
78-00-2
|
19-Dec-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
235-541-3
|
12267-73-1
|
18-Iun-2010
|
Toxic for reproduction (Article 57c) |
Details | |||
262-967-7
|
61788-32-7
|
27-Iun-2018
|
vPvB (Article 57e) |
Details | |||
263-467-1
|
62229-08-7
|
19-Dec-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
232-142-6
|
7789-06-2
|
20-Iun-2011
|
Carcinogenic (Article 57a) |
Details | |||
231-556-4
|
7632-04-4
|
16-Iun-2014
|
Toxic for reproduction (Article 57c) |
Details | |||
show/hide
Borate(2-), tetrahydroxybis[μ-(peroxy-κO1:κO2)]di-, sodium, hydrate (1:2:6)
Nr. CE:
-
| Nr. CAS:
125022-34-6
|
-
|
-
|
16-Iun-2014
|
Toxic for reproduction (Article 57c) |
Details | ||
234-190-3
|
10588-01-9, 7789-12-0
|
28-Oct-2008
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) |
Details | |||
231-889-5
|
7775-11-3
|
18-Iun-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) |
Details | |||
234-363-3
|
11120-22-2
|
19-Dec-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
with lead (Pb) content above the applicable generic concentration limit for ’toxicity for reproduction’ Repr. 1A (CLP) or category 1 (DSD),the substance is a member of the group entry of lead compounds, with index number 082-001-00-6 in Regulation (EC) No 1272/2008
|
272-271-5
|
68784-75-8
|
19-Dec-2012
|
Toxic for reproduction (Article 57c) |
Details | ||
X4261
|
401-850-9
|
255881-94-8
|
17-Ian-2022
|
PBT (Article 57d) |
Details | ||
with ≥0.1% w/w 4-heptylphenol, branched and linear (4-HPbl)
show/hide
Reaction product of 1,3,4-thiadiazolidine-2,5-dithione, formaldehyde and phenol, heptyl derivs.
Nr. CE:
-
| Nr. CAS:
1471311-26-8
Formaldehyde, reaction products with branched and linear heptylphenol, carbon disulfide and hydrazine
Nr. CE:
300-298-5
| Nr. CAS:
93925-00-9
|
-
|
-
|
15-Ian-2018
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
-
|
-
|
17-Dec-2014
|
Toxic for reproduction (Article 57c) |
Details | |||
473-390-7
|
-
|
17-Ian-2023
|
vPvB (Article 57e) |
Details | |||
-
|
232-382-1
|
8012-00-8
|
19-Dec-2012
|
Toxic for reproduction (Article 57c) |
Details | ||
204-927-3
|
129-00-0
|
15-Ian-2019
|
PBT (Article 57d) vPvB (Article 57e) |
Details | |||
234-329-8
|
11103-86-9
|
19-Dec-2011
|
Carcinogenic (Article 57a) |
Details | |||
231-906-6
|
7778-50-9
|
18-Iun-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) |
Details | |||
232-140-5
|
7789-00-6
|
18-Iun-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
Details | |||
-
|
266-028-2
|
65996-93-2
|
13-Ian-2010
|
Carcinogenic (Article 57a) PBT (Article 57d) vPvB (Article 57e) |
Details | ||
201-004-7
|
77-09-8
|
19-Dec-2011
|
Carcinogenic (Article 57a) |
Details | |||
show/hide
|
-
|
-
|
08-Iul-2021
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - environment) Endocrine disrupting properties (Article 57(f) - human health) |
Details | ||
201-581-5
|
85-01-8
|
15-Ian-2019
|
vPvB (Article 57e) |
Details | |||
show/hide
|
-
|
-
|
17-Dec-2015
|
Toxic for reproduction (Article 57c) PBT (Article 57d) |
Details | ||
PFHxS
show/hide
tridecafluorohexanesulphonic acid, compound with 2,2'-iminodiethanol (1:1)
Nr. CE:
274-462-9
| Nr. CAS:
70225-16-0
Phosphonium, triphenyl(phenylmethyl)-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Nr. CE:
-
| Nr. CAS:
1000597-52-3
Ethanaminium, N-[4-[[4-(diethylamino)phenyl][4-(ethylamino)-1-naphthalenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-ethyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Nr. CE:
-
| Nr. CAS:
1310480-24-0
Methanaminium, N-[4-[[4-(dimethylamino)phenyl][4-(ethylamino)-1-naphthalenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Nr. CE:
-
| Nr. CAS:
1310480-27-3
Methanaminium, N-[4-[[4-(dimethylamino)phenyl][4-(phenylamino)-1-naphthalenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Nr. CE:
-
| Nr. CAS:
1310480-28-4
Beta-Cyclodextrin, compd. with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid ion(1-)(1:1)
Nr. CE:
-
| Nr. CAS:
1329995-45-0
Gamma-Cyclodextrin, compd. with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid ion(1-)(1:1)
Nr. CE:
-
| Nr. CAS:
1329995-69-8
Sulfonium, triphenyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Nr. CE:
-
| Nr. CAS:
144116-10-9
Quinolinium, 1-(carboxymethyl)-4-[2-[4-[4-(2,2-diphenylethenyl)phenyl]-1,2,3,3a,4,8b-hexahydrocyclopent[b]indol-7-yl]ethenyl]-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Nr. CE:
-
| Nr. CAS:
1462414-59-0
Iodonium, diphenyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Nr. CE:
-
| Nr. CAS:
153443-35-7
Methanaminium, N,N,N-trimethyl-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid (1:1)
Nr. CE:
-
| Nr. CAS:
189274-31-5
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, compd.with 2-methyl-2-propanamine (1:1)
Nr. CE:
-
| Nr. CAS:
202189-84-2
Iodonium, bis[4-(1,1-dimethylethyl)phenyl]-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Nr. CE:
-
| Nr. CAS:
213740-81-9
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, gallium salt (9CI)
Nr. CE:
-
| Nr. CAS:
341035-71-0
Sulfonium, bis(4-methylphenyl)phenyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Nr. CE:
-
| Nr. CAS:
341548-85-4
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, scandium(3+) salt (3:1)
Nr. CE:
-
| Nr. CAS:
350836-93-0
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, neodymium(3+) salt (3:1)
Nr. CE:
-
| Nr. CAS:
41184-65-0
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, yttrium(3+) salt (3:1)
Nr. CE:
-
| Nr. CAS:
41242-12-0
Sulfonium, (thiodi-4,1-phenylene)bis[diphenyl-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid (1:2)
Nr. CE:
-
| Nr. CAS:
421555-73-9
Iodonium, bis[4-(1,1-dimethylpropyl)phenyl]-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic
Nr. CE:
-
| Nr. CAS:
421555-74-0
Sulfonium, tris[4-(1,1-dimethylethyl)phenyl]-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Nr. CE:
-
| Nr. CAS:
425670-70-8
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, lithium salt (1:1)
Nr. CE:
-
| Nr. CAS:
55120-77-9
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, zinc salt
Nr. CE:
-
| Nr. CAS:
70136-72-0
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, compd. with N,N-diethylethanamine (1:1)
Nr. CE:
-
| Nr. CAS:
72033-41-1
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, sodium salt
Nr. CE:
-
| Nr. CAS:
82382-12-5
Iodonium, bis[(1,1-dimethylethyl)phenyl]-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid (1:1) (9CI)
Nr. CE:
-
| Nr. CAS:
866621-50-3
Sulfonium, (4-methylphenyl)diphenyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Nr. CE:
-
| Nr. CAS:
910606-39-2
Sulfonium, [4-[(2-methyl-1-oxo-2-propen-1-yl)oxy]phenyl]diphenyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Nr. CE:
-
| Nr. CAS:
911027-68-4
Dibenzo[k,n][1,4,7,10,13]tetraoxathiacyclopentadecinium, 19-[4-(1,1-dimethylethyl)phenyl]-6,7,9,10,12,13-hexahydro-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Nr. CE:
-
| Nr. CAS:
928049-42-7
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, cesium salt (1:1)
Nr. CE:
-
| Nr. CAS:
92011-17-1
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, compd. With pyrrolidine (1:1)
Nr. CE:
-
| Nr. CAS:
1187817-57-7
|
-
|
-
|
07-Iul-2017
|
vPvB (Article 57e) |
Details | ||
show/hide
|
-
|
-
|
17-Ian-2023
|
Toxic for reproduction (Article 57c) PBT (Article 57d) vPvB (Article 57e) Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) |
Details | ||
show/hide
1-(4-butoxy-1-naphthalenyl)tetrahydrothiophenium 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfonate
Nr. CE:
468-770-4
| Nr. CAS:
-
N,N,N-triethylethanaminium 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate
Nr. CE:
-
| Nr. CAS:
25628-08-4
|
-
|
-
|
16-Ian-2020
|
Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) |
Details | ||
256-418-0
|
49663-84-5
|
19-Dec-2011
|
Carcinogenic (Article 57a) |
Details | |||
235-067-7
|
12065-90-6
|
19-Dec-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
206-397-9
|
335-67-1
|
20-Iun-2013
|
Toxic for reproduction (Article 57c) PBT (Article 57d) |
Details | |||
276-745-2
|
72629-94-8
|
19-Dec-2012
|
vPvB (Article 57e) |
Details | |||
201-280-9
|
80-46-6
|
12-Ian-2017
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
show/hide
|
-
|
-
|
08-Iul-2021
|
Toxic for reproduction (Article 57c) |
Details | ||
215-235-6
|
1314-41-6
|
19-Dec-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
show/hide
|
700-960-7
|
-
|
23-Ian-2024
|
vPvB (Article 57e) |
Details | ||
D4
|
209-136-7
|
556-67-2
|
27-Iun-2018
|
PBT (Article 57d) vPvB (Article 57e) |
Details | ||
202-429-0
|
95-53-4
|
19-Dec-2012
|
Carcinogenic (Article 57a) |
Details | |||
202-591-2
|
97-56-3
|
19-Dec-2012
|
Carcinogenic (Article 57a) |
Details | |||
show/hide
|
-
|
-
|
12-Ian-2017
|
Toxic for reproduction (Article 57c) PBT (Article 57d) |
Details | ||
202-716-0
|
98-95-3
|
17-Dec-2015
|
Toxic for reproduction (Article 57c) |
Details | |||
-
|
776297-69-9
|
19-Dec-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
201-182-6
|
79-16-3
|
19-Dec-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
213-103-2
|
924-42-5
|
10-Iun-2022
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
Details | |||
200-679-5
|
68-12-2
|
19-Dec-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
204-826-4
|
127-19-5
|
19-Dec-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
202-959-2
|
101-61-1
|
18-Iun-2012
|
Carcinogenic (Article 57a) |
Details | |||
200-879-2
|
75-56-9
|
19-Dec-2012
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
Details | |||
210-894-6
|
625-45-6
|
19-Dec-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
203-615-4
|
108-78-1
|
17-Ian-2023
|
Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) |
Details | |||
UVCB substances consisting of more than or equal to 80% linear chloroalkanes with carbon chain lengths within the range from C14 to C17
show/hide
|
-
|
-
|
08-Iul-2021
|
PBT (Article 57d) vPvB (Article 57e) |
Details | ||
-
|
401-750-5
|
17570-76-2
|
18-Iun-2012
|
Toxic for reproduction (Article 57c) |
Details | ||
235-727-4
|
12626-81-2
|
19-Dec-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
235-038-9
|
12060-00-3
|
19-Dec-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
-
|
215-693-7
|
1344-37-2
|
13-Ian-2010
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | ||
239-290-0
|
15245-44-0
|
19-Dec-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
234-853-7
|
12036-76-9
|
19-Dec-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
215-267-0
|
1317-36-8
|
19-Dec-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
232-064-2
|
7784-40-9
|
28-Oct-2008
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
229-335-2
|
6477-64-1
|
19-Dec-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
233-245-9
|
10099-74-8
|
19-Dec-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
236-542-1
|
13424-46-9
|
19-Dec-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
206-104-4
|
301-04-2
|
16-Dec-2013
|
Toxic for reproduction (Article 57c) |
Details | |||
244-073-9
|
20837-86-9
|
19-Dec-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
-
|
235-759-9
|
12656-85-8
|
13-Ian-2010
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | ||
231-846-0
|
7758-97-6
|
13-Ian-2010
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
237-486-0
|
13814-96-5
|
19-Dec-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
231-100-4
|
7439-92-1
|
27-Iun-2018
|
Toxic for reproduction (Article 57c) |
Details | |||
224-208-8
|
4247-02-3
|
17-Ian-2023
|
Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
202-506-9
|
96-45-7
|
16-Dec-2013
|
Toxic for reproduction (Article 57c) |
Details | |||
206-114-9
|
302-01-2, 7803-57-8
|
20-Iun-2011
|
Carcinogenic (Article 57a) |
Details | |||
including cis- and trans- stereo isomeric forms and all possible combinations of the isomers
show/hide
|
-
|
-
|
19-Dec-2012
|
Respiratory sensitising properties (Article 57(f) - human health) |
Details | ||
and all major diastereoisomers identified
show/hide
|
-
|
-
|
28-Oct-2008
|
PBT (Article 57d) |
Details | ||
206-803-4
|
376-06-7
|
19-Dec-2012
|
vPvB (Article 57e) |
Details | |||
218-165-4
|
2058-94-8
|
19-Dec-2012
|
vPvB (Article 57e) |
Details | |||
203-856-5
|
111-30-8
|
08-Iul-2021
|
Respiratory sensitising properties (Article 57(f) - human health) |
Details | |||
203-727-3
|
110-00-9
|
19-Dec-2012
|
Carcinogenic (Article 57a) |
Details | |||
200-842-0
|
75-12-7
|
18-Iun-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
500-036-1
|
25214-70-4
|
19-Dec-2011
|
Carcinogenic (Article 57a) |
Details | |||
205-912-4
|
206-44-0
|
15-Ian-2019
|
PBT (Article 57d) vPvB (Article 57e) |
Details | |||
292-966-7
|
91031-62-8
|
19-Dec-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
EDA
|
203-468-6
|
107-15-3
|
27-Iun-2018
|
Respiratory sensitising properties (Article 57(f) - human health) |
Details | ||
D6
|
208-762-8
|
540-97-6
|
27-Iun-2018
|
PBT (Article 57d) vPvB (Article 57e) |
Details | ||
215-540-4
|
12179-04-3, 1303-96-4, 1330-43-4
|
18-Iun-2010
|
Toxic for reproduction (Article 57c) |
Details | |||
234-541-0
|
12008-41-2
|
27-Iun-2018
|
Toxic for reproduction (Article 57c) |
Details | |||
217-710-3
|
1937-37-7
|
16-Dec-2013
|
Carcinogenic (Article 57a) |
Details | |||
209-358-4
|
573-58-0
|
16-Dec-2013
|
Carcinogenic (Article 57a) |
Details | |||
278-355-8
|
75980-60-8
|
14-Iun-2023
|
Toxic for reproduction (Article 57c) |
Details | |||
205-017-9
|
131-18-0
|
20-Iun-2013
|
Toxic for reproduction (Article 57c) |
Details | |||
235-702-8
|
12578-12-0
|
19-Dec-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
show/hide
|
-
|
-
|
19-Ian-2021
|
Toxic for reproduction (Article 57c) |
Details | ||
201-861-7
|
88-85-7
|
19-Dec-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
201-058-1
|
77-78-1
|
19-Dec-2012
|
Carcinogenic (Article 57a) |
Details | |||
210-088-4
|
605-50-5
|
19-Dec-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
276-090-2
|
71850-09-4
|
16-Ian-2020
|
Toxic for reproduction (Article 57c) |
Details | |||
201-553-2
|
84-69-5
|
13-Ian-2010
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
201-559-5
|
84-75-3
|
16-Dec-2013
|
Toxic for reproduction (Article 57c) |
Details | |||
200-589-6
|
64-67-5
|
19-Dec-2012
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
Details | |||
DCHP
|
201-545-9
|
84-61-7
|
27-Iun-2018
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - human health) |
Details | ||
246-356-2
|
24613-89-6
|
19-Dec-2011
|
Carcinogenic (Article 57a) |
Details | |||
211-670-0
|
683-18-1
|
19-Dec-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
245-152-0
|
22673-19-4
|
25-Iun-2020
|
Toxic for reproduction (Article 57c) |
Details | |||
201-557-4
|
84-74-2
|
28-Oct-2008
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - environment) Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
215-125-8
|
1303-86-2
|
18-Iun-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
204-650-8
|
123-77-3
|
19-Dec-2012
|
Respiratory sensitising properties (Article 57(f) - human health) |
Details | |||
215-481-4
|
1327-53-3
|
28-Oct-2008
|
Carcinogenic (Article 57a) |
Details | |||
215-116-9
|
1303-28-2
|
28-Oct-2008
|
Carcinogenic (Article 57a) |
Details | |||
D5
|
208-764-9
|
541-02-6
|
27-Iun-2018
|
PBT (Article 57d) vPvB (Article 57e) |
Details | ||
all possible combinations of the cis- and trans-isomers
show/hide
|
-
|
-
|
19-Dec-2012
|
Respiratory sensitising properties (Article 57(f) - human health) |
Details | ||
233-334-2
|
10124-43-3
|
15-Dec-2010
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
233-402-1
|
10141-05-6
|
15-Dec-2010
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
200-755-8
|
71-48-7
|
15-Dec-2010
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
208-169-4
|
513-79-1
|
15-Dec-2010
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
231-589-4
|
7646-79-9
|
28-Oct-2008
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
205-923-4
|
218-01-9
|
15-Ian-2018
|
Carcinogenic (Article 57a) PBT (Article 57d) vPvB (Article 57e) |
Details | |||
215-607-8
|
1333-82-0
|
15-Dec-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
Details | |||
231-904-5
|
7778-44-1
|
19-Dec-2011
|
Carcinogenic (Article 57a) |
Details | |||
215-147-8
|
1306-23-6
|
16-Dec-2013
|
Carcinogenic (Article 57a) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | |||
show/hide
|
233-331-6
|
10124-36-4, 31119-53-6
|
17-Dec-2014
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | ||
show/hide
|
215-146-2
|
1306-19-0
|
20-Iun-2013
|
Carcinogenic (Article 57a) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | ||
233-710-6
|
10325-94-7
|
15-Ian-2018
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | |||
244-168-5
|
21041-95-2
|
15-Ian-2018
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | |||
232-222-0
|
7790-79-6
|
17-Dec-2014
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | |||
show/hide
|
233-296-7
|
10108-64-2
|
16-Iun-2014
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | ||
208-168-9
|
513-78-0
|
15-Ian-2018
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | |||
231-152-8
|
7440-43-9
|
20-Iun-2013
|
Carcinogenic (Article 57a) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
Details | |||
202-318-7
|
94-26-8
|
25-Iun-2020
|
Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
223-445-4
|
3896-11-5
|
23-Ian-2024
|
vPvB (Article 57e) |
Details | |||
EC No. 233-139-2 and EC No. 234-343-4
show/hide
|
-
|
-
|
18-Iun-2010
|
Toxic for reproduction (Article 57c) |
Details | ||
200-268-0
|
56-35-9
|
28-Oct-2008
|
PBT (Article 57d) |
Details | |||
214-604-9
|
1163-19-5
|
19-Dec-2012
|
PBT (Article 57d) vPvB (Article 57e) |
Details | |||
201-247-9
|
80-07-9
|
14-Iun-2023
|
vPvB (Article 57e) |
Details | |||
204-212-6
|
117-82-8
|
19-Dec-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
203-924-4
|
111-96-6
|
19-Dec-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
show/hide
|
-
|
-
|
17-Ian-2023
|
vPvB (Article 57e) |
Details | ||
205-594-7
|
143-24-8
|
19-Ian-2021
|
Toxic for reproduction (Article 57c) |
Details | |||
204-211-0
|
117-81-7
|
28-Oct-2008
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - environment) Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
202-177-1
|
92-67-1
|
19-Dec-2012
|
Carcinogenic (Article 57a) |
Details | |||
201-622-7
|
85-68-7
|
28-Oct-2008
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
205-916-6
|
207-08-9
|
15-Ian-2019
|
Carcinogenic (Article 57a) PBT (Article 57d) vPvB (Article 57e) |
Details | |||
205-883-8
|
191-24-2
|
27-Iun-2018
|
PBT (Article 57d) vPvB (Article 57e) |
Details | |||
200-028-5
|
50-32-8
|
20-Iun-2016
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) PBT (Article 57d) vPvB (Article 57e) |
Details | |||
trimellitic anhydride; TMA
|
209-008-0
|
552-30-7
|
27-Iun-2018
|
Respiratory sensitising properties (Article 57(f) - human health) |
Details | ||
200-280-6
|
56-55-3
|
15-Ian-2018
|
Carcinogenic (Article 57a) PBT (Article 57d) vPvB (Article 57e) |
Details | |||
237-222-4
|
13701-59-2
|
17-Ian-2023
|
Toxic for reproduction (Article 57c) |
Details | |||
231-901-9
|
7778-39-4
|
19-Dec-2011
|
Carcinogenic (Article 57a) |
Details | |||
-
|
292-604-8
|
90640-82-7
|
13-Ian-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) PBT (Article 57d) vPvB (Article 57e) |
Details | ||
-
|
295-278-5
|
91995-17-4
|
13-Ian-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) PBT (Article 57d) vPvB (Article 57e) |
Details | ||
-
|
295-275-9
|
91995-15-2
|
13-Ian-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) PBT (Article 57d) vPvB (Article 57e) |
Details | ||
-
|
292-603-2
|
90640-81-6
|
13-Ian-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) PBT (Article 57d) vPvB (Article 57e) |
Details | ||
-
|
292-602-7
|
90640-80-5
|
13-Ian-2010
|
Carcinogenic (Article 57a) PBT (Article 57d) vPvB (Article 57e) |
Details | ||
204-371-1
|
120-12-7
|
28-Oct-2008
|
PBT (Article 57d) |
Details | |||
223-320-4
|
3825-26-1
|
20-Iun-2013
|
Toxic for reproduction (Article 57c) PBT (Article 57d) |
Details | |||
232-143-1
|
7789-09-5
|
18-Iun-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) |
Details | |||
are fibres covered by index number 650-017-00-8 in Annex VI, part 3, table 3.1 of Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, and fulfil the three following conditions: a) oxides of aluminium and silicon are the main components present (in the fibres) within variable concentration ranges b) fibres have a length weighted geometric mean diameter less two standard geometric errors of 6 or less micrometres (µm) c) alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content less or equal to 18% by weight
show/hide
|
-
|
-
|
19-Dec-2011
|
Carcinogenic (Article 57a) |
Details | ||
287-476-5
|
85535-84-8
|
28-Oct-2008
|
PBT (Article 57d) vPvB (Article 57e) |
Details | |||
201-173-7
|
79-06-1
|
30-Mar-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
Details | |||
show/hide
|
-
|
-
|
15-Dec-2010
|
Carcinogenic (Article 57a) |
Details | ||
257-175-3
|
51404-69-4
|
19-Dec-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
273-688-5
|
69011-06-9
|
19-Dec-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
with ≥ 0.1% of Michler's ketone (EC No. 202-027-5) or Michler's base (EC No. 202-959-2)
|
219-943-6
|
2580-56-5
|
18-Iun-2012
|
Carcinogenic (Article 57a) |
Details | ||
with ≥ 0.1% of Michler's ketone (EC No. 202-027-5) or Michler's base (EC No. 202-959-2)
|
208-953-6
|
548-62-9
|
18-Iun-2012
|
Carcinogenic (Article 57a) |
Details | ||
204-419-1
|
120-71-8
|
19-Dec-2012
|
Carcinogenic (Article 57a) |
Details | |||
204-327-1
|
119-47-1
|
17-Ian-2022
|
Toxic for reproduction (Article 57c) |
Details | |||
201-329-4
|
81-15-2
|
28-Oct-2008
|
vPvB (Article 57e) |
Details | |||
covering any of the individual stereoisomers of [1] and [2] or any combination thereof
show/hide
1,3-Dioxane, 2-[(1S,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
Nr. CE:
-
| Nr. CAS:
676367-06-9
Reaction mass of 5-sec-butyl-2-(2,4-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane and 5-sec-butyl-2-(4,6-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane
Nr. CE:
413-720-9
| Nr. CAS:
-
1,3-Dioxane, 2-(2,4-dimethyl-3-cyclohexen-1-yl)-5-methyl-5-(1-methylpropyl)-
Nr. CE:
-
| Nr. CAS:
117933-89-8
1,3-Dioxane, 2-(2,4-dimethyl-3-cyclohexen-1-yl)-5-methyl-5-(1-methylpropyl)-
Nr. CE:
-
| Nr. CAS:
186309-28-4
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
Nr. CE:
-
| Nr. CAS:
676367-05-8
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-rel-
Nr. CE:
-
| Nr. CAS:
343934-04-3
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
Nr. CE:
-
| Nr. CAS:
676367-09-2
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-rel-
Nr. CE:
-
| Nr. CAS:
343934-05-4
1,3-Dioxane, 2-[(1R,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
Nr. CE:
-
| Nr. CAS:
676367-04-7
1,3-Dioxane, 2-[(1R,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
Nr. CE:
-
| Nr. CAS:
676367-08-1
1,3-Dioxane, 2-[(1S,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
Nr. CE:
-
| Nr. CAS:
676367-03-6
1,3-Dioxane, 2-[(1S,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
Nr. CE:
-
| Nr. CAS:
676367-07-0
1,3-Dioxane, 2-[(1S,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
Nr. CE:
-
| Nr. CAS:
676367-02-5
|
-
|
-
|
15-Iun-2015
|
vPvB (Article 57e) |
Details | ||
202-679-0
|
98-54-4
|
16-Iul-2019
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
substances with a linear and/or branched alkyl chain with a carbon number of 9 covalently bound in position 4 to phenol, ethoxylated covering UVCB- and well-defined substances, polymers and homologues, which include any of the individual isomers and/or combinations thereof
show/hide
Nonylphenol, branched, ethoxylated
1 - 2.5 moles ethoxylated
Nr. CE:
500-209-1
| Nr. CAS:
68412-54-4
44-(nonylphenoxy)-3,6,9,12,15,18,21,24,27,30,33,36,39,42-tetradecaoxatetratetracontanol
Nr. CE:
260-678-0
| Nr. CAS:
57321-10-5
4-Nonylphenol, branched, ethoxylated
1 - 2.5 moles ethoxylated
Nr. CE:
500-315-8
| Nr. CAS:
127087-87-0
3,6,9,12,15,18,21,24,27-Nonaoxanonacosan-1-ol, 29-(isononylphenoxy)-
Nr. CE:
-
| Nr. CAS:
65455-72-3
29-(nonylphenoxy)-3,6,9,12,15,18,21,24,27-nonaoxanonacosanol
Nr. CE:
248-294-1
| Nr. CAS:
27177-08-8
26-(nonylphenoxy)-3,6,9,12,15,18,21,24-octaoxahexacosan-1-ol
Nr. CE:
247-816-5
| Nr. CAS:
26571-11-9
26-(nonylphenoxy)-3,6,9,12,15,18,21,24-octaoxahexacosan-1-ol;
Nr. CE:
255-695-5
| Nr. CAS:
42173-90-0
3,6,9,12-Tetraoxatetradecan-1-ol, 14-(4-nonylphenoxy)-, branched
Nr. CE:
293-926-1
| Nr. CAS:
91648-64-5
|
799-990-1
|
-
|
20-Iun-2013
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
substances with a linear and/or branched alkyl chain with a carbon number of 9 covalently bound in position 4 to phenol, covering also UVCB- and well-defined substances which include any of the individual isomers or a combination thereof
show/hide
|
-
|
-
|
19-Dec-2012
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
202-453-1
|
95-80-7
|
19-Dec-2012
|
Carcinogenic (Article 57a) |
Details | |||
substances with a linear and/or branched alkyl chain with a carbon number of 7 covalently bound predominantly in position 4 to phenol, covering also UVCB- and well-defined substances which include any of the individual isomers or a combination thereof
show/hide
|
-
|
-
|
12-Ian-2017
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
200-453-6
|
60-09-3
|
19-Dec-2012
|
Carcinogenic (Article 57a) |
Details | |||
covering well-defined substances and UVCB substances, polymers and homologues
show/hide
Poly(oxy-1,2-ethanediyl), α-[(1,1,3,3-tetramethylbutyl)phenyl]-ω-hydroxy-
Nr. CE:
-
| Nr. CAS:
9036-19-5
20-[4-(1,1,3,3-tetramethylbutyl)phenoxy]-3,6,9,12,15,18-hexaoxaicosan-1-ol
Nr. CE:
219-682-8
| Nr. CAS:
2497-59-8
|
-
|
-
|
19-Dec-2012
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
205-426-2
|
140-66-9
|
19-Dec-2011
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
201-250-5
|
80-09-1
|
17-Ian-2023
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - environment) Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
show/hide
|
-
|
-
|
19-Dec-2012
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
Details | ||
212-658-8
|
838-88-0
|
19-Dec-2012
|
Carcinogenic (Article 57a) |
Details | |||
Bisphenol A; BPA
|
201-245-8
|
80-05-7
|
12-Ian-2017
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - environment) Endocrine disrupting properties (Article 57(f) - human health) |
Details | ||
202-027-5
|
90-94-8
|
18-Iun-2012
|
Carcinogenic (Article 57a) |
Details | |||
with ≥ 0.1% of Michler's ketone (EC No. 202-027-5) or Michler's base (EC No. 202-959-2)
|
209-218-2
|
561-41-1
|
18-Iun-2012
|
Carcinogenic (Article 57a) |
Details | ||
201-025-1
|
77-40-7
|
08-Iul-2021
|
Endocrine disrupting properties (Article 57(f) - environment) Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
202-974-4
|
101-77-9
|
28-Oct-2008
|
Carcinogenic (Article 57a) |
Details | |||
ZOLDINE MS-PLUS
|
421-150-7
|
143860-04-2
|
19-Dec-2012
|
Toxic for reproduction (Article 57c) |
Details | ||
211-765-7
|
693-98-1
|
25-Iun-2020
|
Toxic for reproduction (Article 57c) |
Details | |||
ACETOCURE 97; GENOCURE*PMP; IGM 4817; IRGACURE 907; SPEEDCURE 97
|
400-600-6
|
71868-10-5
|
16-Ian-2020
|
Toxic for reproduction (Article 57c) |
Details | ||
203-772-9
|
110-49-6
|
16-Iul-2019
|
Toxic for reproduction (Article 57c) |
Details | |||
203-713-7
|
109-86-4
|
15-Dec-2010
|
Toxic for reproduction (Article 57c) |
Details | |||
Sunt afişate 1 - 200 rezultate din 240.